• I am a Health Decision Scientist excited by examining health outcomes, access to care, and value-based health care delivery research. My methods interests include decision science, mathematical modeling, economic evaluation and critical appraisal of clinical trials.

    I was lucky enough to have had a rewarding public health career spanning from field work to desk-based research. In Vietnam, I was an HIV prevention program officer at Abt Associates helping neglected but at high-risk female sexual partners of injection drug users. Our programs coached these women in negotiating safer sex, among other domestic and well-being skills, to eliminate the HIV infection. Alongside with other community-based health care interventions, I was always ruminating over how to obtain the best possible outcomes from the programs within a resource-restricted condition. Then I moved on with research on cost-effectiveness analysis and other economic evaluation methods for the valuation of a variety of health care programs. I applied this skill set in evaluating different management strategies for cervical precancer while being at the UTHealth Health Science Center at Houston and MD Anderson Cancer Center. Modeling the diseases, I developed a desire in further understanding the dearth of parameter inputs, inspiring me to join the SWOG Statistical Center at the Fred Hutch Cancer Research Center to learn about the diffusion of new cancer therapies and to conduct cancer care delivery research. I participated in the projects appraising the ultimate value of randomized cancer clinical trials in contributing verified evidence to the clinical guidelines. Experiencing multiple databases, large and small, I plan for research projects using clinically meaningful linked datasets. My career-long goal is to advocate for the usage of economic evidence to facilitate medical decision-making.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2021 Alabama Screening and Intervention for Glaucoma and Eye Health through Telemedicine (AL-SIGHT): Study Design and MethodologyJournal of Glaucoma.  30:371-379. 2021
    2020 Economic Evaluations in National Cancer Institute–Sponsored Network Cancer Clinical TrialsValue in Health.  23:1653-1661. 2020
    2020 Preliminary study on HIV status disclosure to perinatal infected children: Retrospective analysis of administrative records from a pediatric HIV clinic in the southern United StatesBMC Research Notes.  13. 2020
    2019 Association of National Cancer Institute-Sponsored Clinical Trial Network Group Studies with Guideline Care and New Drug IndicationsJAMA Network Open.  2. 2019
    2019 Cost-Effectiveness of Herpes Zoster Vaccination: A Systematic ReviewPharmacoEconomics.  37:169-200. 2019
    2018 The scientific impact and value of large, NCI-sponsored randomized phase III cancer chemoprevention trials 2018
    2018 Cost-Effectiveness of Competing Treatment Strategies for Clostridium difficile Infection: A Systematic ReviewInfection Control and Hospital Epidemiology.  39:412-424. 2018
    2018 Prevalence and correlates of HIV infection among men who inject drugs in a remote area of VietnamHarm Reduction Journal.  15. 2018
    2016 Post-GAVI sustainability of the Haemophilus influenzae type b vaccine program: The potential role of economic evaluationHuman Vaccines and Immunotherapeutics.  12:2403-2405. 2016
    2016 Overtreatment and cost-effectiveness of the see-and-treat strategy for managing cervical precancerCancer Epidemiology, Biomarkers and Prevention.  25:807-814. 2016
    2016 Disparities in cervical cancer survival among Asian-American womenAnnals of Epidemiology.  26:28-35. 2016
    2015 Economic evaluation of DNA ploidy analysis vs liquid-based cytology for cervical screeningBritish Journal of Cancer.  112:1951-1957. 2015

    Education And Training

  • Doctor of Philosophy in Management Science, The University of Texas Health Science Center at Houston 2017
  • Full Name

  • Van T. Nghiem